Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 94

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 94
---
 U.S.
President Trump’s second term, the U.S. announced the imposition of additional substantial tariffs on imports from various countries,
including China, Canada and Mexico, and the subject countries have imposed or indicated their intention to impose counter measures. In
February 2025, the U.S. imposed tariffs of 10% on all imported goods from China, followed by an additional 10% tariff in March 2025.
The U.S. also imposed a 25% tariff on all steel and aluminum imports, beginning in March 2025. On February 13, 2025, President Trump
ordered his trade advisers to come up with “reciprocal” tariffs on U.S. trade partners to retaliate against taxes, tariffs,
regulations and subsidies and on April 2, 2025, announced new tariffs on many U.S. trading partners, including a universal baseline tariff
of 10% on all imported goods, and country specific tariffs such as an additional 34% tax on imports from China (leading to an effective
rate of 54% when combined with existing tariffs) and 20% on products from the E.U. Specific products that are being tariffed, such as
automobiles, were to be exempted from the new tariffs, and tariffs on products such as pharmaceutical drugs were to be announced at a
later date. Following a period of market turbulence, on April 9, 2025, President Trump announced a 90-day pause to the tariffs announced
on April 2, 2025 for most countries. Countries subject to the pause on the tariffs are still to be subject to the baseline 10% tariff.
This consequently lowers the tariff rate for the E.U., Japan, and South Korea, among other countries. However, U.S. President Trump announced
an increased tariff rate against Chinese imports of a minimum 145%. These and other tariffs and countermeasures could increase the cost
of equipment necessary for our operations, disrupt global supply chains and create additional operational challenges. Additionally, ongoing
trade tensions and uncertainty regarding future trade policies could negatively impact global economic conditions and consumer confidence,
further affecting our business performance.

Any litigation against NewGenIvf could be costly and time-consuming to defend and could harm its business, financial condition and results of operations.

NewGenIvf has in the past
and may in the future become subject to regulatory actions, litigation, disputes, or claims of various types, legal proceedings and claims
that arise in the ordinary course of